Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The muscarinic acetylcholine receptor M3 subtype (M3, CHRM3) is a G protein-coupled receptor that mediates many of the physiological effects of acetylcholine. It is highly expressed in smooth muscle tissues, exocrine glands, endocrine glands, lungs, pancreas, and certain regions of the brain. Activation leads to smooth muscle contraction, glandular secretion, and vascular effects. It is targeted by therapeutic drugs for airway obstructive diseases, urge urinary incontinence, and irritable bowel syndrome.
Gq protein activation leading to Phospholipase C activation, IP3 and DAG production, and increased intracellular calcium concentration
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptor M3 Subtype (M3).